Skip Navigation


JAC Advance Access originally published online on November 12, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/6/1011    most recent
dkh008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cruchaga, S.
Right arrow Articles by Campos, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruchaga, S.
Right arrow Articles by Campos, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 52, 1011-1014
© 2003 The British Society for Antimicrobial Chemotherapy

Molecular basis of rifampicin resistance in Haemophilus influenzae

Susana Cruchaga, María Pérez-Vázquez, Federico Román and José Campos*

Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Majadahonda a Pozuelo, Km 2, 28220 Majadahonda, Madrid, Spain

Received 31 July 2003; returned 15 September 2003; revised 6 October 2003; accepted 6 October 2003

Objectives: To determine the molecular basis of rifampicin resistance in Haemophilus influenzae.

Methods: Mutations in the rifampicin-resistance determining region of the rpoB gene of H. influenzae were analysed by gene amplification and sequencing in 12 rifampicin resistant, one intermediate and four susceptible isolates.

Results: All clinical resistant isolates except one had at least one amino acid substitution in the ß-subunit of RNA polymerase. Eleven resistant isolates had amino acid changes at codons 513, 516, 518, 526 and 533 of cluster I, with the most common amino acid substitution being Asp-516->Val. Only one resistant isolate also had a second mutation Asn-518->Asp in cluster I; transformants obtained with DNA of this isolate also had both mutations. All the amino acid changes in cluster I were detected in isolates with a high level of rifampicin resistance (MIC >= 32 mg/L), except the Asp-516->Ala mutation in a low-level resistant isolate (MIC 4 mg/L). Only one serotype f isolate with an MIC of 2 mg/L had a mutation in cluster II. Cluster III presented no amino acid changes. In in vitro-generated high-level rifampicin-resistant mutants, only amino acid changes at codons 516 and 526 were seen, with new amino acid changes appearing at codon 526 of cluster I, while His-526->Asn was associated with low-level resistance.

Conclusions: Rifampicin resistance in H. influenzae is due to point mutations in the rpoB gene, and the resistance levels are dependent on both the location and the nature of amino acid substitution.

Keywords: H. influenzae, RNA polymerase, rpoB gene

* Corresponding author. Tel: +34-91-8223650; Fax: +34-91-5097966; E-mail: jcampos{at}isciii.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
S. Campoy, J. Aranda, G. Alvarez, J. Barbe, and M. Llagostera
Isolation and Sequencing of a Temperate Transducing Phage for Pasteurella multocida.
Appl. Envir. Microbiol., May 1, 2006; 72(5): 3154 - 3160.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.